Resistance to caspase-8 and -9 fragments in a malignant pleural mesothelioma cell line with acquired cisplatin-resistance

Cell Death and Disease

Volumn 1, Issue 9, 2010, Pages

  Janson, V ^a,b   Johansson, A ^a   Grankvist, K ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b NATIONAL VETERINARY INSTITUTE   (Sweden)

Author keywords

Caspase activity; Caspase fragmentation; Cisplatin resistance; Malignant pleural mesothelioma

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CISPLATIN; ANTINEOPLASTIC AGENT; CASPASE 7; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; DRUG RESISTANCE; ENZYMOLOGY; MESOTHELIOMA; METABOLISM; PLEURA TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HUMANS; MESOTHELIOMA; PLEURAL NEOPLASMS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 79952083494     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2010.54     Document Type: Article

References (34)

1. Kurokawa M, Kornbluth S. Caspases and kinases in a death grip. Cell 2009; 138: 838-854.
2. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008; 9: 231-241. (Pubitemid 351301823)
3. Eckelman BP, Salvesen GS, Scott FL. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 2006; 7: 988-994. (Pubitemid 44480512)
4. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J 1999; 18: 5242-5251. (Pubitemid 29465575)
5. Vaux DL, Silke J. Mammalian mitochondrial IAP binding proteins. Biochem Biophys Res Commun 2003; 304: 499-504. (Pubitemid 36506522)
6. Wajant H. Targeting the FLICE Inhibitory Protein (FLIP) in cancer therapy. Mol Interv 2003; 3: 124-127.
7. Kaufmann SH, Lee S-H, Meng XW, Loegering DA, Kottke TJ, Henzing AJ et al. Apoptosisassociated caspase activation assays. Methods 2008; 44: 262-272.
8. Vaculova A, Zhivotovsky B. Caspases: determination of their activities in apoptotic cells. Methods Enzymol 2008; 442: 157-181.
9. Inoue S, Browne G, Melino G, Cohen GM. Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ 2009; 16: 1053-1061.
10. Ho PK, Hawkins CJ. Mammalian initiator apoptotic caspases. FEBS J 2005; 272: 5436-5453. (Pubitemid 41581660)
11. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009; 16: 3-11.
12. Lindhagen E, Nygren P, Larsson R. The fluorometric microculture cytotoxicity assay. Nat Protoc 2008; 3: 1364-1369.
13. + 2Cl- -cotransport activity and cisplatin-induced early membrane blebbing. Cell Phys Biochem 2008; 21: 45-56.
14. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007; 7: 573-584. (Pubitemid 47106628)
15. Giaccone G. Clinical perspectives on platinum resistance. Drugs 2000; 59 (Suppl 4): 9-17; discussion 37-18. (Pubitemid 30344987)
16. Borst P, Rottenberg S, Jonkers J. How do real tumors become resistant to cisplatin? Cell Cycle 2008; 7: 1353-1359. (Pubitemid 351872573)
17. Ikuta K, Takemura K, Kihara M, Naito S, Lee E, Shimizu E et al. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells. Oncol Rep 2005; 13: 1229-1234.
18. Okouoyo S, Herzer K, Ucur E, Mattern J, Krammer PH, Debatin KM et al. Rescue of death receptor and mitochondrial apoptosis signaling in resistant human NSCLC in vivo. Int J Cancer 2004; 108: 580-587. (Pubitemid 38036659)
19. Yang X, Zheng F, Xing H, Gao Q, Wei W, Lu Y et al. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer. J Cancer Res Clin Oncol 2004; 130: 423-428. (Pubitemid 39044346)
20. Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A et al. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Cancer Res 2003; 63: 513-521. (Pubitemid 36152515)
21. Widlak P, Garrard WT. Discovery, regulation, and action of the major apoptotic nucleases DFF40/CAD and endonuclease G. J Cell Biochem 2005; 94: 1078-1087. (Pubitemid 41420231)
22. Marklund SL, Westman NG, Lundgren E, Roos G. Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res 1982; 42: 1955-1961. (Pubitemid 12103398)
23. Johansson D, Andersson C, Moharer J, Johansson A, Behnam-Motlagh P. Cisplatininduced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells. Br J Cancer 2010; 102: 383-391.
24. Vande Walle L, Lamkanfi M, Vandenabeele P. The mitochondrial serine protease HtrA2/ Omi: an overview. Cell Death Differ 2008; 15: 453-460. (Pubitemid 351267296)
25. Karki P, Seong C, Kim JE, Hur K, Shin SY, Lee JS et al. Intracellular K(+) inhibits apoptosis by suppressing the Apaf-1 apoptosome formation and subsequent downstream pathways but not cytochrome c release. Cell Death Differ 2007; 14: 2068-2075. (Pubitemid 350131156)
26. Checinska A, Hoogeland BS, Rodriguez JA, Giaccone G, Kruyt FA. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation. Exp Cell Res 2007; 313: 1215-1224. (Pubitemid 46427812)
27. Allan LA, Clarke PR. Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation. FEBS J 2009; 276: 6063-6073.
28. Cursi S, Rufini A, Stagni V, Condo I, Matafora V, Bachi A et al. Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression. EMBO J 2006; 25: 1895-1905.
29. Yang C, Kaushal V, Haun RS, Seth R, Shah SV, Kaushal GP. Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity. Cell Death Differ 2008; 15: 530-544. (Pubitemid 351267304)
30. Rehm M, Huber HJ, Dussmann H, Prehn JH. Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. EMBO J 2006; 25: 4338-4349. (Pubitemid 44435231)
31. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 1999; 144: 281-292. (Pubitemid 29066031)
32. Walsh JG, Cullen SP, Sheridan C, Luthi AU, Gerner C, Martin SJ. Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc Natl Acad Sci USA 2008; 105: 12815-12819.
33. Guerrero AD, Chen M, Wang J. Delineation of the caspase-9 signaling cascade. Apoptosis 2008; 13: 177-186.
34. Stennicke HR, Deveraux QL, Humke EW, Reed JC, Dixit VM, Salvesen GS. Caspase-9 can be activated without proteolytic processing. J Biol Chem 1999; 274: 8359-8362. (Pubitemid 29164620)